The Anti-Inflammatory Drugs Market Revenue was valued at USD 95.23 billion in 2023 and is projected to grow significantly, reaching USD 177 billion by 2032, with a CAGR of 7.13% during the forecast period 2024-2032. The market's growth is fueled by rising incidences of chronic inflammatory diseases, an aging population, and advancements in pharmaceutical innovations.Key Drivers of Market GrowthT..